A Randomized, Double-Blind, Parallel Study to Evaluate the Dose-Response of Three Different Vitamin D Treatment Schemes on the 25-Hydroxyvitamin D Serum Concentration in Patients with Vitamin D Deficiency

Marie-Louise Schleck, Jean-Claude Souberbielle, Bernard Jandrain, Stéphanie Da Silva, Sophie De Niet, Francis Vanderbist, André Scheen, Etienne Cavalier, Marie-Louise Schleck, Jean-Claude Souberbielle, Bernard Jandrain, Stéphanie Da Silva, Sophie De Niet, Francis Vanderbist, André Scheen, Etienne Cavalier

Abstract

Many people worldwide are vitamin D (VTD) deficient or insufficient, and there is still no consensus on the dose of VTD that should be administered to achieve a 25(OH)D concentration of 20 or 30 ng/mL. In this study, we aimed to determine an adapted supplementation of VTD able to quickly and safely increase the vitamin D status of healthy adults with low 25(OH)D. One hundred and fifty (150) subjects were randomized into three groups, each to receive, orally, a loading dose of 50,000, 100,000 or 200,000 IU of VTD3 at Week 0, followed by 25,000, 50,000 or 100,000 IU at Week 4 and Week 8. Whereas 25(OH)D baseline values were not different between groups (p = 0.42), a significant increase was observed at Week 12 (p < 0.0001) with a mean change from baseline of 7.72 ± 5.08, 13.3 ± 5.88 and 20.12 ± 7.79 ng/mL. A plateau was reached after eight weeks. No related adverse event was recorded. This study demonstrated a linear dose-response relationship with an increase in 25(OH)D levels proportional to the dose administered. In conclusion, a loading dose of 200,000 IU VTD3 followed by a monthly dose of 100,000 IU is the best dosing schedule to quickly and safely correct the VTD status.

Keywords: randomized double-blind trial; safety; vitamin D.

Figures

Figure 1
Figure 1
Evolution of 25(OH)D (ng/mL) over time.

References

    1. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266–281. doi: 10.1056/NEJMra070553.
    1. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M., Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J. Clin. Endocrinol. Metab. 2011;96:53–58. doi: 10.1210/jc.2010-2704.
    1. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 2012;97:1153–1158. doi: 10.1210/jc.2011-2601.
    1. Bruyère O., Slomian J., Beaudart C., Buckinx F., Cavalier E., Gillain S., Petermans J., Reginster J.Y. Prevalence of vitamin D inadequacy in European women aged over 80 years. Arch. Gerontol. Geriatr. 2014;59:78–82. doi: 10.1016/j.archger.2014.03.010.
    1. Weng F.L., Shults J., Leonard M.B., Stallings V.A., Zemel B.S. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am. J. Clin. Nutr. 2007;86:150–158.
    1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group KDIGO Clinical Practice Guidelines for the Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int. 2009 doi: 10.1038/ki.2009.188.
    1. Eastell R., Brandi M.L., Costa A.G., Amour P.D., Shoback D.M., Thakker R.V. Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 2014;99:3570–3579. doi: 10.1210/jc.2014-1414.
    1. Rizzoli R., Boonen S., Brandi M.-L., Bruyère O., Cooper C., Kanis J.A., Kaufman J.-M., Ringe J.D., Weryha G., Reginster J.-Y. Vitamin D supplementation in elderly or postmenopausal women: A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Curr. Med. Res. Opin. 2013;29:305–313. doi: 10.1185/03007995.2013.766162.
    1. Adams J.S., Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010;95:471–478. doi: 10.1210/jc.2009-1773.
    1. Cavalier E., Faché W., Souberbielle J.C. A randomised, double-blinded, placebo-controlled, parallel study of vitamin D3 supplementation with different schemes based on multiples of 25,000 IU doses. Int. J. Endocrinol. 2013 doi: 10.1155/2013/327265.
    1. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003;77:204–210.
    1. Autier P., Gandini S., Mullie P. A systematic review: Influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J. Clin. Endocrinol. Metab. 2012;97:2606–2613. doi: 10.1210/jc.2012-1238.
    1. McKenna M.J., Murray B.F. Vitamin D dose response is underestimated by Endocrine Society’s Clinical Practice Guideline. Endocr. Connect. 2013;2:87–95. doi: 10.1530/EC-13-0008.
    1. Ilahi M., Armas L.A.G., Heaney R.P. Pharmacokinetics of a single, large dose of cholecalciferol. Am. J. Clin. Nutr. 2008;87:688–691.
    1. Roth D.E., Al Mahmud A., Raqib R., Black R.E., Baqui A.H. Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women. Nutr. J. 2012;11:114. doi: 10.1186/1475-2891-11-114.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel